Registered entities
Zenas Biopharma, Inc.
Reg. No. 1953926United States
Innovation
8 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 188 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 4 |
Social engagement
Social engagement: 13.5K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
21 investors on record; lead investors include Enavate Sciences, SR One, New Enterprise Associates, Delos Capital Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 57% |
| Private equity | 3 | 14% |
| Other / undisclosed | 6 | 29% |
Hiring activity
Hires occasionally
4 roles tracked across 2 of the last 12 months
7 Apr 2026 · Director, Investor Relations and Corporate Communications · Waltham
7 Apr 2026 · Director, Advertising & Promotion · Waltham
2 Mar 2026 · Clinical Project Manager · Waltham
2 Mar 2026 · Senior Director, Regulatory Affairs CMC · Waltham
Based on job postings tracked across public sources.
Recent activity
12 Jun 2026
Event
H.C. Wainwright & Co., LLC 7th Annual Neuro Perspectives Expert Summit
3 Jun 2026
Event
EULAR 2026
28 May 2026
Event
EULAR 2026